Home > Quotes > ABBV

AbbVie Inc. Common Stock Quote & Summary Data

ABBV 
$61.2
*  
0.50
0.82%
Get ABBV Alerts
*Delayed - data as of Apr. 28, 2016  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

AbbVie Inc. Common Stock Intraday Chart




News for ABBV

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 62.10 $ 71.60
Low $ 57.53 $ 45.45

The current last sale of $61.20 is 34.65% Higher thanthe 52 week low.

P/E Ratio

ETFs with ABBV as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
4.65% Market Vectors Pharmaceutical ETF (PPH) -5.66 (-8.69%)
3.47% SPDR Select Sector Fund - Health Care (XLV) -0.46 (-0.64%)
3.27% iShares U.S. Healthcare ETF (IYH) -3.50 (-2.32%)
3.12% Vanguard Health Care ETF - DNQ (VHT) -2.69 (-2.03%)
2.96% WisdomTree U.S. Quality Dividend Growth Fund (DGRW) +0.55 (1.77%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

AbbVie(1) was incorporated in Delaware on April 10, 2012. On January 1, 2013, AbbVie became an independent company as a result of the distribution by Abbott Laboratories (Abbott) of 100 percent of the outstanding common stock of AbbVie to Abbott's shareholders. AbbVie's common stock began trading "regular-way" under the ticker symbol "ABBV" on the New York Stock Exchange on January 2, 2013. Overview AbbVie is a global, research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address some of the world's most complex and serious diseases.  ... More ...  

Risk Grade

Where does ABBV fit in the risk graph?


Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?